allodynia and tirzepatide In four recent placebo-controlled clinical trials, dysesthesia, an unpleasant sensation that's perceived on or under the skin, was reported as a side effect of the GLP-1 agonist semaglutide in 5-23% of recipients PDF) Allodynia and Dysesthesia Associated

Treat it as a framework, not a buying recommendation

It is important to recognise that whilst uncomfortable, nausea from Rybelsus is generally not indicative of serious harm and typically improves over time

Observational studies have demonstrated that individuals with obesity are at substantially higher risk of developing lymphoedema following cancer treatment, and those with established lymphoedema experience greater symptom burden and functional impairment when overweight or obese

Risk of Increased Blood Pressure Substantial increases in blood pressure may occur following CYANOKIT therapy

Missing occasional doses does not significantly impact results